The Effect of Inspiratory Muscle Training in Post COVID-19 Patients
Covid19, Infective Pneumonia
About this trial
This is an interventional treatment trial for Covid19 focused on measuring Inspiratory Muscle Training, Post-COVID 19, Respiratory Muscle Strength, Respiratory Function, Functional Capacity
Eligibility Criteria
Inclusion Criteria:
- Adults ages 18-70
- Being clinically stable,
- Having COVID-19 infection and at least 6 weeks after infection
- Being between Grade 2-4 according to Post-COVID Functional Status Scale
- Regular participation in treatment
- To read, write and understand Turkish
- Volunteering to participate in research
Exclusion Criteria:
- Presence of mental and cognitive impairments
- Having an orthopedic, neurological disease that prevents exercise
- Uncontrolled hypertension, having a cardiovascular disease
- Pregnancy and breastfeeding
Sites / Locations
- Istinye UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Study Group
Control group
In the study group, Inspiratory Muscle Training will be applied with Threshold IMT device (Respironics, USA) at 40% of the maximum inspiratory pressure value for eight weeks, every day of the week, twice a day for 15 minutes. The patients will come for a control once a week, the maximum inspiratory pressure will be measured again and the new training intensity will be determined at 40% of the new maximum inspiratory pressure.
In the control group, Inspiratory Muscle Training will be applied with Threshold IMT device (Respironics, USA) at 10% of the maximum inspiratory pressure value for eight weeks, every day of the week, twice a day for 15 minutes. The exercise workload will not be increased and will remain the same. It will run at 10% of maximum inspiratory pressure for eight weeks.